Coronavirus in Hungary – First patients receive domestically produced Remdesivir
The first few Hungarian patients have received doses of the domestically manufactured Covid-19 drug Remdesivir at the clinic of Debrecen University, the university’s press office said on Tuesday.
The drug was given to Covid patients with chronic underlying illnesses first on Monday, the press office told MTI in a statement.
The domestic manufacture of Remdesivir is under way by pharmaceutical company Richter.
Richter has already produced enough clinical trial doses in the initial phase to treat some 250 patients, the innovation and technology ministry said last Friday.
By the end of the month, the drug will be available in enough doses to treat more than 800 patients, a state secretary at the ministry said in a statement. The government contributed 400 million forints (EUR 1.1m) to Richter’s production of the drug, József Bódis said.
Mass manufacture in Hungary of the antiviral drug favipiravir is also under way, Bódis said.
More news about CORONAVVIRUS IN HUNGARY
Read alsoHungary records its highest daily death toll from COVID-19
Source: MTI
please make a donation here
Hot news
GreenGo, a convenient way to get to Budapest Airport: perfect alternative of the 100E shuttle bus
Albanian Antifa activist arrested in Paris over violent clashes in Budapest
Winter’s roar: Severe weather warning as cold front hits Hungary
PHOTOS: Budapest’s Chain Bridge lights up in solidarity with Ukraine
Is your luck running out? These Hungarian superstitions could change everything!
UEFA Nations League: Hungary levels the score against Germany in 99th minute, Szalai receives thoughtful gift – PHOTOS
2 Comments
Today, the 16th October, the WHO have released a statement saying that ‘Remdesivir makes no substantive to the recovery of patients’.
Reuters reports that the EU wants to renegotiate its order for the drug, now that it has been proven to be of no use in clinical trials.